| CAS ID: | 63-39-8 |
| Molecular Formula: | C9H15N2O15P3 |
| Molecular Weight: | 484.1 g/mol |
| Monoisotopic Mass: | 483.9685 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | Uridine triphosphate | UTP | Uridine-5'-triphosphate |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C9H15N2O15P3/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(24-8)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,22)(H,10,12,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1 | See All |
| InChI Key: | PGAVKCOVUIYSFO-XVFCMESISA-N | |
| Smiles: | O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(=O)(O)OP(=O)(O)OP(=O)(O)O)N2C=CC(=O)NC2=O | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT00004705 | Disease | Cystic fibrosis |
| Phase | Not Applicable | Status | Completed |
| First Received | February 25, 2000 | Last Verified | March 25, 2015 |
| Sponsor | FDA Office of Orphan Products Development | ||
| PubChem: | 6133 |
| ChEMBL: | CHEMBL336296 |